Grants and Contributions:
Title:
Scale-up and Optimization of Linear Covalently Closed DNA Ministrings (msDNA) Production
Agreement Number:
933784
Agreement Value:
$125,000.00
Agreement Date:
Jul 15, 2019 - Jul 31, 2020
Description:
This project will enable large-scale production of ministring DNA transgene delivery vector by improving fermentation and purification efficiency. Increased production capacity will support Mediphage's genetic medicine program.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5G 0B7
Reference Number:
172-2019-2020-Q2-933784
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
788308328
Recipient Type:
For-profit organization
Recipient's Legal Name:
Mediphage Bioceuticals, Inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171